Duality Advisers, LP Regenxbio Inc. Transaction History

Duality Advisers, LP

  • $995 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022
SELL
$24.62 - $34.31 $549,050 - $765,147
-22,301 Closed
0 $0
Q4 2021

Feb 02, 2022
BUY
$30.19 - $40.28 $673,267 - $898,284
22,301 New
22,301 $729,000
Q2 2021

Aug 09, 2021
SELL
$32.46 - $40.48 $674,713 - $841,417
-20,786 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$33.61 - $49.95 $698,617 - $1.04 Million
20,786 New
20,786 $709,000

Others Institutions Holding RGNX

# of Institutions
192
Shares Held
42.6M
Call Options Held
80.6K
Put Options Held
55.2K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $590M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email